Robert G. Conway

Robert G. Conway discloses dealings in Agile Therapeutics Inc to SEC (Form 4). We count 8 filings; the first trade dates from 24 January 2019 and the latest from 26 August 2024.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The record was last updated on 26 August 2024 with a transaction (€4,634) in Agile Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.